This refers to the cumulative uptake of at least one vaccine dose of any vaccine product and is presented by age group. It is calculated as follows: number of first doses cumulatively administered divided by the size of the population The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18.
This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented by age group. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18.
This refers to the cumulative uptake of the first booster dose and is presented by age group. See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18.
First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals.
This refers to the cumulative uptake of the second booster dose and is presented by age group. See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18.
Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course.
This refers to the cumulative uptake of the third booster dose and is presented by age group. See definition of third booster below. It is calculated as follows: number of third booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN. Countries reporting data by age groups in adults may differ from those reporting data in under 18.
Third booster: for surveillance purpose, this refers to third additional doses of COVID-19 vaccines administered after the standard primary course. Therefore, the count and uptake estimates may include both third booster doses administered to immunocompetent persons and third additional doses administered to immunocompromised individuals after a standard primary course.
The number of first doses administered is cumulative and it refers only to the total number of vaccine doses administered as first dose of 2-dose vaccination course products.
The number of complete primary courses administered is cumulative and it refers to the total number of primary courses administered defined according to the authorised schedule for each vaccine product at EU level (e.g. second dose of 2-dose vaccination course products, as well as first dose of single dose vaccination course products such as Janssen).
The number of booster doses administered is cumulative and based on the definition of first, second and third boosters described above.
This graph shows the proportion of vaccine doses administered overall (as first, second, booster or unspecified dose) by age group out of the total number of doses administered.
Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation.
Please refer to the Notes on the data tab to export the full data set.